Article
Temporal Changes Guided by Mesenchymal Stem Cells on a 3D Microgel Platform Enhances Angiogenesis In Vivo at a Low-Cell Dose
2020-05-19
Abstract excerpt
Therapeutic factors secreted by mesenchymal stem cells (MSCs) promote angiogenesis in vivo . However, delivery of MSCs in the absence of a cytoprotective environment offers limited efficacy due to low cell retention, poor graft survival and the non-maintenance of a physiologically relevant dose of growth factors at the injury site. The delivery of stem cells on an extracellular matrix (ECM)-based platform alters...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2b9aec81-cc94-57e0-8c53-e37e74e23f8a
- DOI
- 10.1101/2020.05.16.086298
